The cost of Xofluza (baloxavir marboxil) can vary depending on several factors, including insurance coverage, pharmacy, and geographic location. While specific pricing details are not publicly disclosed by the manufacturer, out-of-pocket costs for patients can range significantly.
How much does Xofluza generally cost without insurance?
Without insurance, the list price of Xofluza can be substantial. Some sources indicate a retail price in the hundreds of dollars for a single course of treatment. However, this figure is often subject to discounts or patient assistance programs.
Can I get help with the cost of Xofluza?
Patient assistance programs may be available to help reduce the financial burden of Xofluza. These programs are typically offered by the drug manufacturer or through third-party foundations. Eligibility for these programs often depends on income and insurance status. Information on these programs can usually be found on the official Xofluza website or by inquiring at a pharmacy.
How does Xofluza's price compare to other flu treatments?
Xofluza is an oral antiviral medication, and its pricing reflects its unique mechanism of action, which differs from older flu treatments like oseltamivir (Tamiflu) or zanamivir (Relenza). Comparisons of cost are best made by checking current prices at local pharmacies and factoring in available coupons or insurance co-pays for all options.
When does Xofluza's patent protection expire?
Information regarding the specific patent expiration dates for Xofluza and its related intellectual property can be found through patent tracking resources. DrugPatentWatch.com provides a database of drug patents, including those for Xofluza, which can help determine when generic versions might become available [1]. The availability of generics typically leads to a decrease in drug prices.
What is the mechanism of action for Xofluza?
Xofluza is a first-in-class selective inhibitor of the cap-dependent endonuclease of the influenza virus polymerase acidic (PA) endonuclease [2]. By inhibiting this enzyme, Xofluza prevents the virus from replicating.
What is Xofluza used for?
Xofluza is approved for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours [2]. It is also approved for post-exposure prophylaxis of influenza in individuals 12 years of age and older [2].
Sources:
1. DrugPatentWatch.com
2. Xofluza Prescribing Information